125 related articles for article (PubMed ID: 25108207)
1. Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide.
Choe JY; Kim SK
Clin Chim Acta; 2015 Jan; 438():29-34. PubMed ID: 25108207
[TBL] [Abstract][Full Text] [Related]
2. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis.
Costa NT; Scavuzzi BM; Iriyoda TMV; Lozovoy MAB; Alfieri DF; de Medeiros FA; de Sá MC; Micheletti PL; Sekiguchi BA; Reiche EMV; Maes M; Simão ANC; Dichi I
Clin Exp Med; 2018 Aug; 18(3):363-372. PubMed ID: 29644482
[TBL] [Abstract][Full Text] [Related]
4. Leflunomide-associated infections in rheumatoid arthritis.
Jenks KA; Stamp LK; O'Donnell JL; Savage RL; Chapman PT
J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
[TBL] [Abstract][Full Text] [Related]
5. The hypouricemiant effect of leflunomide.
Arida D; Silva L; Skare TL
Joint Bone Spine; 2014 May; 81(3):273-4. PubMed ID: 24289959
[No Abstract] [Full Text] [Related]
6. Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients.
Tchetverikov I; Kraan MC; van El B; Hanemaaijer R; DeGroot J; Huizinga TW
Ann Rheum Dis; 2008 Jan; 67(1):128-30. PubMed ID: 17875551
[TBL] [Abstract][Full Text] [Related]
7. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.
Rodriguez-Rodriguez L; Jover-Jover JA; Fontsere O; Peña-Blanco RC; León L; Fernández-Gutierrez B; Abásolo L
Scand J Rheumatol; 2013; 42(6):433-6. PubMed ID: 23742043
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
Goldenberg MM
Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
[TBL] [Abstract][Full Text] [Related]
10. The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis.
Klimiuk PA; Kita J; Chwiecko J; Sierakowski S
Clin Rheumatol; 2009 Jan; 28(1):17-21. PubMed ID: 18663553
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis.
Kullich WC; Mur E; Aglas F; Niksic F; Czerwenka C
Clin Exp Rheumatol; 2006; 24(2):155-60. PubMed ID: 16762150
[TBL] [Abstract][Full Text] [Related]
12. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J
J Rheumatol; 2012 Jun; 39(6):1171-8. PubMed ID: 22505700
[TBL] [Abstract][Full Text] [Related]
13. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.
Wiacek R; Kolossa K; Jankowski T; Jeka S; Karmowski A; Karmowski M; Gworys B
Adv Clin Exp Med; 2012; 21(3):337-42. PubMed ID: 23214197
[TBL] [Abstract][Full Text] [Related]
15. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G
Arthritis Rheum; 1999 Sep; 42(9):1870-8. PubMed ID: 10513801
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
Rajakulendran S; Gadsby K; Deighton C
Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106
[TBL] [Abstract][Full Text] [Related]
17. Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis.
Panoulas VF; Douglas KM; Milionis HJ; Nightingale P; Kita MD; Klocke R; Metsios GS; Stavropoulos-Kalinoglou A; Elisaf MS; Kitas GD
J Hum Hypertens; 2008 Mar; 22(3):177-82. PubMed ID: 17960169
[TBL] [Abstract][Full Text] [Related]
18. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
Narváez J; Díaz-Torné C; Ruiz JM; Hernández MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM
Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
[TBL] [Abstract][Full Text] [Related]
20. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
Flendrie M; Creemers MC; Welsing PM; van Riel PL
Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]